Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain ...

Ozempic has gained a lot of popularity with many referring to it as the miracle weight loss drug However how much do you ...

A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Boots Online Doctor has revealed the 'very common' side-effects of Mounjaro you need to know about after thousands of people ...

The UK’s drug regulator is to study possible serious side effects of glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro). Data from ...

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.

Migraines are a common ailment worldwide, affecting nearly 15% of the global population. At times, they can be debilitating ...

According to the CDC, 1 in 5 American adults is living with obesity. In recent years, many have turned to weight loss drugs ...

Patients have reported being hospitalised with inflammation of the pancreas suspected to be related to medicines such as ...